Viewing Study NCT01872260


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-01-06 @ 7:48 PM
Study NCT ID: NCT01872260
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-29
First Post: 2013-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module